Doximity Inc. Reports Strong Financial Performance with Adjusted EBITDA Rising to $313.8 Million for Fiscal Year 2025

Reuters
2025/05/21
Doximity Inc. Reports Strong Financial Performance with Adjusted EBITDA Rising to $313.8 Million for Fiscal Year 2025

Doximity Inc. has reported its financial results for the fiscal year ending March 31, 2025. The company's net income rose significantly to $223.185 million, compared to $147.582 million in the previous fiscal year. Similarly, the adjusted EBITDA showed substantial growth, reaching $313.8 million, up from $230.5 million in the prior year. The net revenue retention rate for Doximity Inc. also increased, standing at 119% for the fiscal year 2025, an improvement from the 114% recorded in 2024. This growth reflects the company's ability to retain and expand revenue from existing customers. A key operational highlight includes the company's focus on its Marketing Solutions, where customers purchase subscriptions for tailored content on the Doximity platform. The company's performance in this area is marked by a robust customer base, with numerous customers contributing over $500,000 in trailing 12-month subscription revenue. These results highlight Doximity Inc.'s ongoing growth and its continued focus on enhancing productivity for physicians and improving patient care.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Doximity Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001516513-25-000056), on May 20, 2025, and is solely responsible for the information contained therein.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10